Summary
This study was to evaluate the efficacy and safety of early application of citicoline in the treatment of patients with acute stroke by meta-analysis. Randomized controlled trials published until May 2015 were electronically searched in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, WHO International Clinical Trial Registration Platform, Clinical Trial.gov, and China Biology Medicine disc. Two reviewers independently screened the articles and extracted the data based on the inclusion and exclusion criteria. The quality of included articles was evaluated by using Revman5.0, and meta-analysis was performed. The results showed that 1027 articles were obtained in initial retrieval, and finally 7 articles, involving a total of 4039 cases, were included for analysis. The meta-analysis showed that no significant differences were found in the long-term mortality (OR=0.91, 95% CI 0.07 to 1.09, P=0.30), the rate of dependency (OR=1.02, 95% CI 0.87 to 1.24, P=0.85), and the effective rate (OR=0.98, 95% CI 0.84 to 1.14, P=0.82) between citicoline group and control group. The overall rate of adverse events in citicoline group was not significantly different from that in control group (P=0.30). The quality of included articles reached moderate-low level. In conclusion, citicolne cannot reduce long-term mortality and dependence rate in the treatment of acute stroke, and the effective rate of citivoline may be not better than that of controls but with reliable safety.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
World Health Organization. World Health statistics 2008. Geneva, Switzerland. http://www.who.int/whosis/ whostat/ EN_WHS08_Full.pdf
The Atlas of heart disease and stroke, WHO 2004. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf (Mackay J, Mensah G: The Atlas of Heart Disease and Stroke. Geneva, Switzerland, World Health Organization, 2004)
Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation, 2011,123(4): e18–e209
Sousa RM, Ferri CP, Acosta D, et al. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet, 2009,374(9704):1821–1830
Feigin VL, Lawes CM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol, 2003,2(1):43–53
Yue J, Xiao Y, Yan Z. Analysis of influence on the hospitalization expenditure of medical insurant patients with stroke. Mod Prev Med 2008;35:71–73
Secades JJ, Frontera G. CDP-choline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol, 1995,17(Suppl B):1–54
Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke, 1988,19(2):211–216
Sobrino T, Rodriguez-Gonzalez R, Blanco M, et al. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke. Neurol Res, 2011,33(6):572–577
Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusionweighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol, 2000,48(5):713–722
Cho HJ, Kim YJ. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases. Methods Find Exp Clin Pharmacol, 2009,31(3): 171–176
Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke, 2002, 33(12):2850–2857
Davalos A, Alvarez-Sabin J, Castillo J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet, 2012,380(9839):349–357
Chinese Association of Neurosurgery, Chinese Society of Neurosciences. Diagnostic key points of cerebrovascular diseases. Chin J Neurol, 1996,6:60–61
WHO Special Report. Stroke: recommendations on stroke prevention, diagnosis and therapy. Stroke, 1989,20(10): 1407–1431
Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions (version 5.1.0). Chichester: John Wiley & Sons, Ltd, 2011:1–28
Higgins JPT, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions (version 5.1.0). Chichester: John Wiley & Sons, Ltd, 2011:1–53
Clark WM, Warach SJ, Pettigrew LC, et al. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology, 1997,49(3):671–678
Clark WM, Williams BJ, Selzer KA, et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke, 1999,30(12):2592–2597
Clark WM, Wechsler LR, Sabounjian LA, et al. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology, 2001,57(9): 1595–602
Secades JJ, Alvarez-Sabin J, Rubio F, et al. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis, 2006,21(5-6):380–385
Mitta M, Goel D, Bansal KK, et al. Edaravone-citicoline comparative study in acute ischemic stroke (ECCS-AIS). J Assoc Physicians India, 2012,60(hg7, 7505585):36–38
Lin WX. The therapeutic effect of edaravone for acute cerebral infarction. Chin J Integ Med Cardio-/Cerebrovasc Dis (Chinese), 2007,5(3):205–207
Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke, 1988,19(2):211–216
Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol, 2006, 28(Suppl B):1–56
Iranmanesh F, Vakilian A. Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial. J Stroke Cerebrovasc Dis, 2008,17(3):153–155
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shi, Py., Zhou, Xc., Yin, Xx. et al. Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 270–277 (2016). https://doi.org/10.1007/s11596-016-1579-6
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-016-1579-6